Synapse - Anmol Kirankumar Shah

Anmol Kirankumar Shah

Research Focus

Medicine; Research Regulatory Associate

https://orcid.org/0009-0002-7295-2775

Recent additions – View all

Chemotherapy-sparing induction followed by consolidation and maintenance with blinatumomab and concurrent oral tyrosine kinase inhibitor therapy for newly-diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: Primary endpoint results from the BLISSPHALL study
Meeting Abstract

Geyer, M. B.; Mascarenhas, J.; Smith, M.; Pascual, S.; Shah, A.; Silvestrone, M. R.; Czaplinska, T.; Johnson, K.; Thompson, M. C.; Park, J. H.
Blood (2023)

Fulltext@MSK | Save

Co-authors at MSK

1

Geyer
1

Park
1

Pascual
1

Silvestrone
1

Smith
1

Thompson

Types of Work

Publications

Blood (1)